Association between Androgenic Hormone Levels and Left Ventricular Ejection Fraction

Gholamreza Davoodi1, Alireza Amirzadegan, Mohammad Ali Boroumand

  • 1Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Lower free testosterone (fT) levels are associated with reduced left ventricular ejection fraction (EF) in men. This finding suggests a link between androgen levels and heart failure severity, warranting further investigation.

Area of Science:

  • Cardiology
  • Endocrinology
  • Heart Failure Research

Background:

  • Androgens exert varied effects on the cardiovascular system.
  • Previous research indicates a connection between androgens and cardiovascular health.
  • This study investigates androgen levels in relation to left ventricular ejection fraction (EF).

Purpose of the Study:

  • To compare androgenic hormone levels across different left ventricular ejection fraction (EF) groups.
  • To identify potential associations between specific androgens and reduced EF.
  • To explore the relationship between free testosterone (fT) and severe heart failure.

Main Methods:

  • Analysis of 515 men undergoing echocardiography and coronary angiography.
  • Classification of patients into four EF groups: <35%, 35-45%, 45-54%, and ≥55%.
  • Measurement of serum androgens: free testosterone (fT), total testosterone (tT), and dehydroepiandrosterone sulfate (DHEAS).
  • Comparative analysis between patients with EF <35% and EF ≥35%.

Main Results:

  • Higher EF levels correlated with lower incidence of diabetes, coronary artery lesions, and C-reactive protein (CRP).
  • A statistically significant trend was observed in baseline characteristics across EF groups.
  • Patients with EF <35% exhibited significantly lower free testosterone (fT) levels compared to those with EF ≥35% (p < 0.05).

Conclusions:

  • A significant association exists between reduced free testosterone (fT) levels and left ventricular ejection fraction (EF) <35%.
  • The findings suggest a potential link between low fT and severe heart failure.
  • Further prospective studies are needed to establish a causal relationship.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...